Breast Neoplasms: all 12,820 studies
Page 27 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Telehealth Program to Prevent Cancer and Chemotherapy-related Cognitive Impairment.Enrolling by invitationNCT04783402Not applicable
- Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.RecruitingNCT04778839Phase 1
- MicroRNA Profiles in Triple Negative Breast CancerRecruitingNCT04771871Phase 2
- Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast CancerRecruitingNCT04768426Phase 2
- Monitoring Response to NAC and Prediction of pCR in Breast Cancer Patients Using Optical ImagingRecruitingNCT04767659Not applicable
- TKIs vs. Pertuzumab in HER2+ Breast Cancer Patients With Active Brain Metastases (HER2BRAIN)Not yet recruitingNCT04760431Phase 2
- Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer PatientsRecruitingNCT04751435Not applicable
- Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for HER2 Positive Early Breast Cancer PatientsRecruitingNCT04750122Phase 1/2
- Targeted Resection of Axillary Metastatic Lymph Nodes After Breast Cancer Neoadjuvant ChemotherapyRecruitingNCT04744506Not applicable
- Repeat Sentinel Lymph Node Biopsy in Ipsilateral Breast Tumor RecurrenceRecruitingNCT04741737Not applicable
- Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast CancerRecruitingNCT04740697Not applicable
- Evaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Breast CancerRecruitingNCT04739670Phase 2
- Inetetamab Plus Rapamycin and Chemotherapy for HER2+ Metastatic Breast Cancer With Abnormal Activation of PAM PathwayNot yet recruitingNCT04736589Phase 3
- Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in SituRecruitingNCT04722692Phase 3
- Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and ModeratorsRecruitingNCT04722341Not applicable
- Effects of Expectations and Body Image in Breast ReconstructionRecruitingNCT04714463
- Evaluation of Innovative Therapeutic Approaches of Vaginal and Sexual Dysfunction After Breast Cancer TreatmentRecruitingNCT04713917Not applicable
- Development of Patient Derived Xenografts (PDX) in Patients With Breast CancerRecruitingNCT04703244
- Local Therapy for ER/PR-positive Oligometastatic Breast CancerRecruitingNCT04698252Phase 2
- 3D Ultrasound Breast ImagingRecruitingNCT04692818Not applicable
- Photobiomodulation Therapy for the Management of Breast Cancer-related LymphedemaRecruitingNCT04690439Not applicable
- Primary Surgical Prevention of Breast Cancer-related LymphedemaRecruitingNCT04687956Not applicable
- A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast CancerRecruitingNCT04683679Phase 2
- Single Fraction Preoperative Radiotherapy for Early Stage Breast CancerRecruitingNCT04679454Not applicable
- Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast CancerRecruitingNCT04671511Not applicable
- Accelerated Partial Breast Irradiation Versus Standard or Hypofractionated Whole-Breast Irradiation, in Early Breast Cancer, After Breast-conserving SurgeryRecruitingNCT04669873Not applicable
- Nomogram to Predict Breast Cancer Related LymphedemaRecruitingNCT04665882Not applicable
- To Identify Primary Resistance to CDK4/6 Inhibitors in Breast CancerRecruitingNCT04660435
- Nab-paclitaxel in Combination With Pyrotinib in Postoperative Adjuvant Therapy for HER2-positive Breast CancerNot yet recruitingNCT04659499Phase 2
- Diffusion-Weighted MRI for Diagnosis of Multifocal, Multicentric Breast CancerRecruitingNCT04656639
- Preventing Chemotherapy-induced Peripheral Neuropathy Using PRESIONA Exercise ProgramRecruitingNCT04652609Not applicable
- Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural SciencesRecruitingNCT04650256Not applicable
- Fulvestrant or Capecitabine Combined With Pyrotinib in HR+/HER2+ Metastatic Breast CancerRecruitingNCT04646759Phase 3
- Radiotherapy for Extracranial Oligometastatic Breast CancerRecruitingNCT04646564Phase 3
- A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib StudyRecruitingNCT04641247Phase 2
- Refining Local-Regional Therapy for IBCRecruitingNCT04636710Not applicable
- Research on the Heterogeneity of Taiwanese Breast Cancer Patients by Next Generation Sequencing (NGS) ToolsRecruitingNCT04626440
- A Master Protocol Empowering Mechanobiology Translation Research in Breast CancerRecruitingNCT04625023
- DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte MaturationRecruitingNCT04616729Phase 1/2
- Exercise and Cognitive (Brain) Function in Breast Cancer Patients Getting Chemotherapy After Breast SurgeryRecruitingNCT04616300
- Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant AbemaciclibRecruitingNCT04614194Phase 2
- Integrated Patient Avatars for Guiding Systemic Therapy Treatments in Metastatic Breast Cancer PatientsRecruitingNCT04608357
- Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast CancerRecruitingNCT04603209
- The MASTER Study (MAmmary Cancer STatin ER Positive Study)RecruitingNCT04601116Phase 3
- What is the Best Interval to Screen Women 45-49 and 70-74 for Breast Cancer?RecruitingNCT04590560Not applicable
- Researching the Effect of Exercise on CancerRecruitingNCT04589468Not applicable
- The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)RecruitingNCT04585750Phase 1/2
- Efficacy and Safety of Dose-dense Chemotherapy (ddEC-ddP) for Neoadjuvant Chemotherapy of HER2-negative Breast CancerRecruitingNCT04576143Phase 2/3
- Combined Immunotherapies in Metastatic ER+ Breast CancerRecruitingNCT04563507Phase 2
- Prospective Study of Immune Alterations in Operable Breast and Ovarian CarcinomaRecruitingNCT04562623
- Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid TumorsRecruitingNCT04557449Phase 1/2
- Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast CancerRecruitingNCT04553770Phase 2
- A Comparison of Nab-PHP and TCbHP Efficacy in Neoadjuvant Therapy for HER2-positive Early Breast CancerRecruitingNCT04547907Phase 3
- Evaluation of Sleep Quality in Prostate Cancer Patients Undergoing Treatment With Hormonal Therapeutic Approaches and in Patients With Full-resected Early Breast CancerRecruitingNCT04543799
- Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast CancerRecruitingNCT04530890Not applicable
- 177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast CancerRecruitingNCT04529044Phase 2
- Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 InhibitorsRecruitingNCT04526587
- ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast CancerRecruitingNCT04523857Phase 2
- A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast CancerRecruitingNCT04521764Phase 1
- Evaluating Omitting of Internal Mammary Irradiation Among Early Stage Intermediate Risk (N1) Breast CancerRecruitingNCT04517266Not applicable
- Early Detection of CMP in Patients With Breast Cancer Using Cardiac Magnetic ResonanceRecruitingNCT04510532
- Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Adjuvant Radiotherapy of Breast CancerRecruitingNCT04506476Not applicable
- Real Time Molecular Analysis of Breast Cancer Receiving Neo-adjuvant ChemotherapyRecruitingNCT04504747
- A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After NAC in TNBCRecruitingNCT04501523Phase 2
- Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in NigeriaRecruitingNCT04501419Not applicable
- Comparison Trial of Open-tip Pulsed Needle Biopsy and Conventional Core Biopsy in Axillary Lymph NodesRecruitingNCT04500262Not applicable
- Experiment on the Use of Innovative Computer Vision Technologies for Analysis of Medical Images in the Moscow Healthcare SystemRecruitingNCT04489992
- Prospective Breast Cancer BiobankingEnrolling by invitationNCT04488614
- Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast CancerRecruitingNCT04486495
- Application of Radiomics in Breast CancerRecruitingNCT04483804
- Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast CancerRecruitingNCT04481932Phase 2
- Coping After Breast Cancer - a Randomized Clinical Trial With Two Digital InterventionsRecruitingNCT04480203Not applicable
- Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine TherapyRecruitingNCT04476485
- Cancer Genetic Testing in Ethnic PopulationsRecruitingNCT04475640Not applicable
- HYPofractionated Adjuvant RadioTherapy in 1 Versus 2 Weeks in High-risk Patients With Breast Cancer (HYPART).RecruitingNCT04472845Not applicable
- Diet Modification in pAtients With Luminal Early Breast Cancer Candidate for Primary SurgeryRecruitingNCT04469296Not applicable
- A Phase I/II Multicenter, Open-Label Study of Lu-177-DOTAGA-IAC, for the Treatment of Angiogenic Breast Cancer Patients.Not yet recruitingNCT04469127Phase 1/2
- Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBCRecruitingNCT04468061Phase 2
- Evaluation of the Efficacy of a Physical Therapy-yoga-patient Educational Program for Breast Cancer Patients With Pain Due to Hormonal Therapy Treatment.RecruitingNCT04457895Not applicable
- Identification and Preservation of Arm LymphaticsRecruitingNCT04446494Not applicable
- Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant ChemotherapyRecruitingNCT04437160Phase 2
- Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)RecruitingNCT04434040Phase 2
- Multi-4SCAR-T Therapy Targeting Breast CancerNot yet recruitingNCT04430595Phase 1/2
- Photoacoustic Imaging for Characterizing Breast Masses and Breast Tumor Response to Neoadjuvant ChemotherapyRecruitingNCT04428528
- A Prospective Cohort Study Comparing Disparity in Surgical Procedure (Wide Local Excision Only vs Any Other Surgery Procedures) Among the Elderly Breast Cancer PatientsNot yet recruitingNCT04426136
- SBRT for Breast Cancer OligometastasesRecruitingNCT04424732Not applicable
- A Trial Evaluating the Efficacy of Metastasectomy in Patients With Oligo-Metastatic Breast Cancer(OMIT)RecruitingNCT04413409Not applicable
- A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2RecruitingNCT04400695Phase 3
- AXillary Surgery After NeoAdjuvant TreatmentRecruitingNCT04373655
- Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 YearsRecruitingNCT04373564Phase 4
- Personalized Second Chance Breast Conservation (PSCBC): A Prospective Phase II Clinical StudyRecruitingNCT04371913Not applicable
- Study to Investigate Efficacy of a Novel Probiotic on the Bacteriome and Mycobiome of Breast CancerRecruitingNCT04362826Not applicable
- SABER Study for Selected Early Stage Breast CancerRecruitingNCT04360330Not applicable
- Improving Theempowerment in Patients With Severe Breast Fibrosis Radio-induced Treated by Pravastatin : Benefit of e-PROs (Electronic " Patient Reported Outcome ") on Breast-related Quality of LifeRecruitingNCT04356209Phase 2
- Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid TumorsRecruitingNCT04354064
- ctDNA Monitoring in Early Breast CancerRecruitingNCT04353557
- East Asian Breast Cancer Genome Atlas and Recurrence Risk PredictionRecruitingNCT04344496
- Intra-operative PET-CT: a Novel Approach to Determine Excision Margins in Lumpectomy Breast Cancer.RecruitingNCT04343079Not applicable
- Predictive Toxicity Test Linked to Radiotherapy After Mastectomy and Immediate Implant ReconstructionRecruitingNCT04342546Not applicable
- Anti-HER2 Therapy + Fulvestrant/Capecitabine in Women With HR+, HER2+, Non-visceral Metastases Stage IV Breast CancerNot yet recruitingNCT04337658Phase 3